TNDM 8-K: Fda approval
Filed with the SEC on · accession 0001438133-26-000148
TNDM filed a 8-K (current report) with the SEC on Nov 13, 2026. Tandem Diabetes Care received FDA 510(k) clearance for its Tandem Mobi tubeless automated insulin delivery system with up to 7 days of wear, making it the only pump offering both tubeless and tubed infusion options.
Summary of the filing
Tandem Diabetes Care received FDA 510(k) clearance for its Tandem Mobi tubeless automated insulin delivery system with up to 7 days of wear, making it the only pump offering both tubeless and tubed infusion options. Full commercial launch in the U.S. is planned for the first half of 2027.
Key details
✦ Ask GOAX AI about this filing — what it means for TNDM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TNDM?
Click hereFrequently asked questions
What did TNDM file with the SEC on Nov 13, 2026?
TNDM filed a 8-K (Fda approval). Tandem Diabetes Care received FDA 510(k) clearance for its Tandem Mobi tubeless automated insulin delivery system with up to 7 days of wear, making it the only pump offering both tubeless and tubed infusion options. Full commercial launch in the U.S. is planned for the first half of 2027.
What does a fda approval mean for TNDM stock?
For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other TNDM SEC filings
- SCHEDULE 13G · SEC filingNov 9, 2026
- 10-Q · SEC filingNov 5, 2026
- 8-K · SEC filingNov 5, 2026
- 8-K · Guidance raiseAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 144 · Insider sale plannedJun 17, 2026
- 8-K · SEC filingMay 21, 2026
- 144 · Insider sale plannedMay 19, 2026
- 8-K · SEC filingMay 15, 2026
- 8-K · Guidance raiseMay 7, 2026
Get alerts when TNDM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days